A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

May 22, 2025

Study Completion Date

May 22, 2025

Conditions
Parenteral Nutrition
Interventions
DRUG

Numeta G16%E

Numeta G16%E (1000mL) will be given intravenously via peripherally inserted central catheter and will provide an equimolar IV phosphate dose of 8.7 mmol over 9 h.

DRUG

Sodium Glycerophosphate Injection

Organic phosphate (SGP) will be diluted 1000mL of sodium chloride (0.9% normal saline) to achieve an equimolar IV phosphate dose of 8.7 mmol over 9 h.

Trial Locations (1)

78744

Austin PPD CRU, Austin

All Listed Sponsors
lead

Baxter Healthcare Corporation

INDUSTRY

NCT06842134 - A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E | Biotech Hunter | Biotech Hunter